CNO Financial suffers $529M quarterly loss on reinsurance deal
Carmel-based insurance holding company CNO Financial Group Inc. on Wednesday reported a big third-quarter loss despite sales growth in all three of its business units.
Health Care & Life Sciences
Articles
NCAA, Pentagon, IU medical school broaden concussion research on student-athletes
The NCAA, which has been sued dozens of times for its role in handling concussions, will help fund an expanded $22.5 million study to examine the impacts of head injuries.
Tobacco, opioid epidemics claimed 14,200 Hoosier lives in 2017, studies say
Two reports, sponsored by the Richard M. Fairbanks Foundation, say the state should not let up in fighting twin scourges that claim thousands of lives and cost billions of dollars in health care costs and lost productivity.
Shoppers may face hard choices again on health marketplaces
Much of the insurance left on the Affordable Care Act marketplaces limits patients to narrow networks of hospitals or doctors and provides no coverage outside those networks.
IU Health covets big prize, but neurosurgery practice clings to independence
Indiana University Health Physicians is setting its sights on one of the state’s last independent specialty holdouts, the neurosurgical Goodman Campbell Brain and Spine.
Purdue delays health care changes for employees’ spouses
The plan approved by Purdue trustees on Oct. 12 met widespread opposition from faculty and staff.
State study panel makes no recommendation on medical marijuana
Indiana lawmakers listened to more than three hours of testimony Thursday afternoon about whether Indiana should allow for medical marijuana usage but did not come to any consensus on the issue.
Endocyte acquisition gives Novartis key therapy—at almost 200 times its last price
One year ago, Indiana-based Endocyte Inc. bought the rights to a prostate cancer treatment for $12 million, plus future considerations. On Thursday, Novartis AG agreed to pay almost 200 times that amount to acquire Endocyte and the experimental therapy.
BioCrossroads forms $9M seed fund for life science startups
The Indiana Seed Fund III is an early-stage fund focused on developing startups in life sciences, health IT and agricultural biosciences.
Indy-based ER physicians’ group sues Fayette Regional Health for fraud, breach of contract
The physicians’ group claims the Connersville health system misled it on patient volumes and has refused to adjust a subsidy to make up the difference.
CVS-Aetna deal given go-ahead by U.S. antitrust regulators
The Justice Department’s approval clears the way for a merger that will create a health care giant with a hand in insurance, prescription-drug benefits and drugstores across the United States.
Generic drugmakers get boost as FDA plan helps complex copycats
The U.S. Food and Drug Administration will make it easier for pharmaceutical companies to bring more complex—and more profitable—generic drugs to market, throwing the struggling industry a crucial lifeline.
Opioid epidemic showing signs of turning corner, state drug czar says
Visits to emergency rooms in Indiana for drug overdoses are falling, and doctors are writing fewer prescriptions for opioid painkillers, Jim McClelland said Friday.
Migraine drug from Eli Lilly approved by FDA
Eli Lilly and Co. received clearance Thursday from U.S. regulators for a new migraine drug that will be the third in a promising class of therapies for patients who suffer from the recurrent, painful headaches.
St. Vincent to buy 30 acres in Carmel—site of earlier controversy with neighbors
The Indianapolis health system said it has not yet decided how to develop the site, but wants to keep its options open. It dropped plans four months ago to rezone the land after neighbors objected.
Ranking hospitals is serious business, but do patients pay attention?
Indiana University Health isn’t shy about telling the world how it stacks up in U.S. News & World Report’s “Best Hospital” annual rankings.
IU Health might build replacement hospital in Frankfort
The Indianapolis-based health system said it is in discussions with officials from Frankfort and Clinton County to build a new hospital to replace a 25-bed facility that is more than 60 years old.
UPDATE: Elanco shares rise 50 percent in first day after $1.5B animal-health IPO
The Eli Lilly and Co.-owned animal medicine maker’s shares rose to $36 each at closing Thursday, up from their $24 offering price.
Lilly’s Elanco animal-health business raises $1.5 billion in IPO
Greenfield-based Elanco Animal Health Inc. raised more than expected in its initial public offering, pricing its shares above the marketed price range.
Competitor beats Lilly to market with migraine drug approval
The competition for the multi-billion dollar migraine market is set to heat up with the FDA expected to decide on Lilly’s migraine therapy next month.